Boehringer Ingelheim Says It’s Agreed To Settle 2,935 Connecticut Pradaxa Suits
HARTFORD, Conn. — German drug maker Boehringer Ingelheim Pharmaceuticals Inc. on Nov. 6 told the Connecticut Supreme Court that it has reached a global settlement for all 2,935 U.S. lawsuits alleging...To view the full article, register now.
Already a subscriber? Click here to view full article